Elevated guanidinoacetate was identified in 8.42% (25/297) of the patients and GAMT deficiency was excluded in 52% (13/25) of those patients either by normal brain MRS or by normal molecular genetic investigations or both (Table 3). This evidence concerns the gene GAMT and hyperinsulinemic hypoglycemia, familial, 4.